Research and Markets: Down Syndrome Pipeline Insights Report 2015

Research and Markets (http://www.researchandmarkets.com/research/6vm7fq/down) has announced the addition of the "Down Syndrome-Pipeline Insights, 2015" subscription to their offering.

This Down Syndrome-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Down Syndrome.

This report provides information on the therapeutic development based on the Down Syndrome dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

1. Down Syndrome Overview
2. Down Syndrome Pipeline Therapeutics
3. Down Syndrome Therapeutics under Development by Companies
4. Down Syndrome Late Stage Products (Filed and Phase III)
5. Comparative Analysis
6. Down Syndrome Mid Clinical Stage Products (Phase II)
7. Comparative Analysis
8. Down Syndrome Early Clinical Stage Products (Phase I and IND Filed)
9. Comparative Analysis
10. Down Syndrome Discovery and Pre-Clinical Stage Products
11. Comparative Analysis
12. Drug Candidate Profiles
13. Down Syndrome - Therapeutics Assessment
14. Assessment by Monotherapy Products
15. Assessment by Combination Products
16. Assessment by Route of Administration
17. Assessment by Molecule Type
18. Down Syndrome - Discontinued Products
19. Down Syndrome - Dormant Products
20. Companies Involved in Therapeutics Development for Down Syndrome
21. Appendix

For more information visit http://www.researchandmarkets.com/research/6vm7fq/down